lobbying_filings_raw: f66bcc4c-7cbb-4e20-ae9a-55e84eb42fc2

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
f66bcc4c-7cbb-4e20-ae9a-55e84eb42fc2 Q4 33545 ROCK & ASSOCIATES 141945 PRECISION PHARMACY 2017 fourth_quarter 2018-01-17T12:31:30.837000-05:00 11250.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/f66bcc4c-7cbb-4e20-ae9a-55e84eb42fc2/", "filing_uuid": "f66bcc4c-7cbb-4e20-ae9a-55e84eb42fc2", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2017, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f66bcc4c-7cbb-4e20-ae9a-55e84eb42fc2/print/", "filing_document_content_type": "text/html", "income": "11250.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "James W. Rock", "dt_posted": "2018-01-17T12:31:30.837000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "517 C Street, NE", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 33545, "url": "https://lda.senate.gov/api/v1/registrants/33545/", "house_registrant_id": 30422, "name": "ROCK & ASSOCIATES", "description": "Government relations consultant.", "address_1": "517 C Street, NE", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JAMES W. ROCK", "contact_telephone": "+1 703-627-8226", "dt_updated": "2025-02-03T11:57:31.624210-05:00"}, "client": {"id": 141945, "url": "https://lda.senate.gov/api/v1/clients/141945/", "client_id": 176, "name": "PRECISION PHARMACY", "general_description": "Compounding Pharmacy.", "client_government_entity": false, "client_self_select": null, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2016-06-01"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Patient Access to Compounded Medications Act of 2017.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Appropriations to fund the FDA implementation of compounding pharmacy regulations.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 22837, "prefix": null, "prefix_display": null, "first_name": "JAMES", "nickname": null, "middle_name": "W", "last_name": "ROCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 30422 CA CA US US Compounding Pharmacy. 0 0        

Links from other tables